Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2043221 | 0.91 | CHRM2 (0.49) | CYP1A2CYP2C9CYP2C19CHRM2LMNA | |
| SCHEMBL1238407 | 0.86 | LMNA (0.60) | CYP1A2CYP2C9CYP2C19CHRM2LMNA | |
| SCHEMBL49257 | 0.82 | CYP1A2 (0.60) | CYP1A2CYP2C9CYP2C19CHRM2LMNA | |
| SCHEMBL7311322 | 0.82 | LMNA (0.47) | CYP1A2CYP2C9CYP2C19CHRM2LMNA | |
| SCHEMBL19056885 | 0.81 | CYP1A2 (0.53) | CYP1A2CYP2C9CYP2C19CHRM2LMNA | |
| SCHEMBL7930638 | 0.80 | CYP1A2 (0.57) | CYP1A2CYP2C9CYP2C19CHRM2LMNA | |
| SCHEMBL2042318 | 0.80 | ALDH1A1 (0.47) | CHRM2LMNACHRM1ALOX15TSHR | |
| SCHEMBL19612454 | 0.79 | SMN1; SMN2 (0.74) | CYP1A2CYP2C9CYP2C19CHRM2LMNA | |
| SCHEMBL29091824 | 0.79 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19CHRM2LMNA | |
| SCHEMBL6709141 | 0.79 | CYP1A2 (0.52) | CYP1A2CYP2C9CYP2C19CHRM2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110210322-A1 | POLYMER COMPOUND CONTAINING NITROGEN-CONTAINING HETEROCYCLIC STRUCTURE, AND COMPOSITION, SOLUTION, THIN FILM AND POLYMER LIGHT-EMITTING ELEMENT EACH CONTAINING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-01 | — | — | US | disclosed |
| EP-2336215-A1 | POLYMER COMPOUND CONTAINING NITROGEN-CONTAINING HETEROCYCLIC STRUCTURE, AND COMPOSITION, SOLUTION, THIN FILM AND POLYMER LIGHT-EMITTING ELEMENT EACH CONTAINING SAME | Sumitomo Chemical Company, Limited (JP) | 2011-06-22 | — | — | EP | disclosed |
| US-4300942-A | N-(Substituted carbonyl) derivatives of N-phos-phinylmethylglycinates and the herbicidal use thereof | MONSANTO COMPANY (US) | 1981-11-17 | — | — | US | disclosed |
| US-4251258-A | N-(Substituted carbonyl) derivatives of N-phosphinylmethylglycinates and the herbicidal use thereof | MONSANTO COMPANY (US) | 1981-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110210322-A1 | POLYMER COMPOUND CONTAINING NITROGEN-CONTAINING HETEROCYCLIC STRUCTURE, AND COMPOSITION, SOLUTION, THIN FILM AND POLYMER LIGHT-EMITTING ELEMENT EACH CONTAINING SAME | H1-10, RNF10, F10 | CYP1A2 589/4885CYP2C9 2014/4885CYP2C19 1609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.